Study Status:
Open
Study Description:
POST MI/HFrEF
Study Name: BioCardia
Study Objective: To evaluate safety/efficacy of CardiAMP cell therapy system in patients with post MI HF.
Key Inclusion Criteria:
- Previous MI (> 6 months)
- EF ≥ 20% and ≤ 40% by echo
- On stable evidence-based medical and device therapy for HF or post-infarction left ventricular dysfunction
Key Exclusion Criteria:
- GFR < 30
- Have a mechanical aortic valve or heart constrictive device
- AS or AI > 2+
- CHB or QTc interval >550 ms
Principal Investigator:
Maria Karas, MD
Contact:
PI: Maria Karas, MD (646) 962 5555
RC: Katelyn Bastert, (212) 746 2698